Zota Health Care LImited has informed the Exchange about Investor Presentation
ZOTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zota Health Care, which runs India's largest private generic pharmacy chain Davaindia, shared its Q4FY25/FY25 investor presentation. FY25 consolidated revenue grew 62% YoY to ₹29,298 lakhs, gross profit jumped 86% YoY to ₹15,567 lakhs, and Davaindia's GMV reached ₹24,562 lakhs. The store network expanded to 1,582 active stores (852 COCO + 730 FOFO), with 702 new stores added during the year. Management targets adding 800-900 more COCO stores by FY26. However, the company slipped into deeper losses, with FY25 PAT at -₹5,855 lakhs versus -₹1,435 lakhs in FY24, and EBITDA turned negative at -₹367 lakhs versus +₹871 lakhs last year, reflecting margin pressure from rapid store expansion and rising employee and operating costs.
Strong top-line growth and aggressive store expansion are positives, but widening losses and negative EBITDA signal that scale has not yet translated into profitability. Investors should watch whether the 800-900 new store plan translates into operating leverage and a return to positive margins in the coming quarters.